š¹ Scientific poster accepted at AACR Ovarian Cancer Conference
š¹ Strategic partnership signed with Prestige Biopharma for pancreatic cancer
š¹ Imagion supports Breast Cancer Awareness Month in October
š¹ Upcoming events and other news
Questions? Email us at: investor@imagionbio.com
MELBOURNE ā Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSenseĀ® HER2 Phase 2 Study Immediate Priority
Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The
Weāre on a mission to make cancer more detectable.
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
Ā© Imagion Biosystems, Ltd. All Rights Reserved |Ā Privacy PolicyĀ |Ā Terms & Conditions | Careers | Corporate Governance